The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
Rehab S Abdul-MaksoudNearmeen M RashadWalid S H ElsayedRasha S ElsayedMagda M SherifAhmad AbbasMohamed El ShabrawyPublished in: The journal of gene medicine (2021)
Our results suggested that decreased plasma ADAMTS9-AS2 expression might act as a novel non-invasive tumor biomarker in NSCLC diagnosis. Furthermore, plasma ADAMTS9-AS2 might predict aggressive tumor behavior.